34728696|PMC8563977
{'Disease', 'Species', 'CellLine', 'Gene'}
The Sputnik V is a COVID- 19 vaccine developed by the Gamalia institute of epidemiology and microbiology and released on August 11, 2020. The mean age of vaccine recipients who submitted for adverse events were 39.32 +- 10.19, and it ranged between 19 and 78 years old with a median of 38 years old; 38.8% were men and 61.2% were women (Table1).The local and systemic side effect reported within 8 days after injection of the first and the second dose of the Sputnik V vaccine is shown in Table 2. reported local side effect in the injection site (1.4 times after the first dose of Oxford-AstraZeneca and 1.2 times after the first dose of Pfizer-BioNTech) and systemic side effects (1.6 times after the first dose of Oxford-AstraZeneca and 2.9 times after the first dose of Pfizer-BioNTech) were higher in individuals previously infected than in those without known past COVID-19 infection.